| The reason of the increase (decrease) in the net profit during the current quarter compared to the same quarter of the last year is | Net profit increases in general due to:1. Decrease in selling and distribution expenses in the Pharmaceuticals sector2. Decrease in general and administrative expenses in the following sectors:a) Pharmaceuticalsb) Other3. Increase in other income in the following sectors:c) Pharmaceuticalsd) Other4. Decrease in loss from discontinued operationWhile noting that there is decrease in gross profit in the Pharmaceuticals sector. |
| The reason of the increase (decrease) in the net profit during the current quarter compared to the previous quarter of the current year is | Net profit decrease in general due to:1. Previous quarter included gain from discontinued operation2. Decrease in gross profit in the following sectors:a) Specialty chemicalb) PharmaceuticalsGross profit decrease was partially offset by increase in gross profit in power and steel sector.3. Increase in general and administrative expenses in the following sectors:a) Specialty chemicalb) Pharmaceuticals4. Increase in provision for impairment of financial assets expense in the following sectors:a) Pharmaceuticalsb) Power and steelWhile noting that there is increase in other income in Pharmaceuticals and Other sector. |
| The reason of the increase (decrease) in the net profit during the current period compared to the same period of the last year is | Net profit increases in general due to:1. Gain from discontinued operation2. Decrease in other expenses in pharmaceuticals sector.3. Increase in sales and gross profit in the following sectors:a) Specialty chemicalb) Pharmaceuticals4. Decrease in provision for impairment of financial assets in all sectors.While noting that there is increase in selling and distribution expenses and general and administrative expenses in pharmaceuticals sector. |
| Statement of the type of external auditor’s report | Unmodified conclusion |
| Reclassification of Comparison Items | Certain comparative figures for the previous period have been reclassified to be consistent with the presentation of the current period. |
| Additional Information | 1. Net Shareholders’ Equity at the end of the period was SR 1,714,921,175 /- compared to SR 1,448,185,342 /- at the end of the similar period last year with an increase of 18%.2. With the completion of the sale of Al Anmaa during the nine month period, the financial results and statements of Al Tanmiya were accounted for in accordance with IFRS requirements. Please refer to Note 13 of the condensed interim consolidated financial statements for further details. |
